Toggle navigation
Home
Search
Services
Blog
Contact
About
Synaptobrevin and Neurotransmitter Release
Deitcher, David Lawrence
Stanford University, Stanford, CA, United States
Search 3 grants from David Deitcher
Search grants from Stanford University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Research Training in Pediatric Critical Care Medicine
ACTION - A CHF Trial Investigating Outcomes of Exercise
Invertebrate Hemoglobins
Infasurf (Calf Lung Surfactant Extract) in Premature Human Infants
Effects of Chemical Carcinogens/Mutagens on Gene Expression
Recently added grants:
AIBP therapy
Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis
Plasmonically Enhanced Point-of-care Detection of Cardiac Biomarkers by a Smart Phone
Role of endothelin in hypertension-mediated inflammation and end-organ damage
The Structural Basis of Antiarrhythmic Drug Binding in Voltage-gated Ion Channels
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32NS009727-01
Application #
2261634
Study Section
Neurology C Study Section (NEUC)
Project Start
1995-04-01
Project End
Budget Start
1994-11-01
Budget End
1995-10-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Stanford University
Department
Biophysics
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Related projects
NIH 1996
F32 NS
Synaptobrevin and Neurotransmitter Release
Deitcher, David Lawrence / Stanford University
NIH 1994
F32 NS
Synaptobrevin and Neurotransmitter Release
Deitcher, David Lawrence / Stanford University
Publications
Kennerdell, Jason R; Liu, Nan; Bonini, Nancy M
(2018)
MiR-34 inhibits polycomb repressive complex 2 to modulate chaperone expression and promote healthy brain aging.
Nat Commun 9:4188
Comments
Be the first to comment on David Deitcher's grant